Glaucoma is one of the leading causes of permanent blindness in the world, affecting more than two million Americans, and more than one hundred million people worldwide. It is a disease of the optic ...

SAN FRANCISCO, California — Laser trabeculoplasty procedures can fail in 30% to 40% of patients with glaucoma, and they will need additional treatment to control their eye disease, according to 2 new ...

Medication, laser, and surgery are all methods of treating glaucoma according to Jonathan Eisengart, MD. Jonathan Eisengart, MD, an ophthalmologist at Cleveland Clinic, explained how different ...

There is no question that the past 5 decades have been transformative for ophthalmologists and their patients. As part of ...

BOSTON — Considering the recent technological progress of femtosecond laser platforms, aided by 3-D imaging, glaucoma surgeons may now find femtosecond lasers beneficial in their own practices, ...

Scientists are testing a new laser surgery device specifically designed to make glaucoma procedures safer, simpler and faster. The revolutionary non-penetrating technique will be easily mastered by ...

Please provide your email address to receive an email when new articles are posted on . Frailty and older age are associated with significantly lower odds of undergoing surgery or laser treatment for ...

Neil Minkoff, MD: As we move into different types of therapy, laser therapy is another viable treatment option. We try to understand patients on drops vs patients with implants vs patients with laser ...

BOZEMAN, MT – November 04, 2025 – PRESSADVANTAGE – Glaucoma continues to be one of the most significant causes of vision loss across the country, often developing slowly and without obvious warning ...

Using anti-inflammatory medications after glaucoma laser surgery is not helpful or necessary, new research concludes. Glaucoma is the most common cause of irreversible blindness in the world, and is ...

LOS ANGELES & MUNICH--(BUSINESS WIRE)--ELT Sight, Inc. today announced the company has acquired the IP and assets of MLase AG’s excimer ophthalmic laser system for glaucoma surgery. MLase manufactures ...